{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Antibody-drug_Conjugate_SC-007",
  "nciThesaurus": {
    "casRegistry": "",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "An antibody-drug conjugate (ADC) composed of a monoclonal antibody against an undisclosed tumor-associated antigen (TAA) linked to an as of yet undisclosed cytotoxic agent, with potential antineoplastic activity. Upon intravenous administration, the monoclonal antibody moiety of SC-007 targets and binds to the TAA expressed on tumor cells. Upon binding and internalization, the cytotoxic agent is released and kills the TAA-expressing cancer cells, through an as of yet unknown mechanism of action.",
    "fdaUniiCode": "4NP0CFH7QL",
    "identifier": "C147029",
    "preferredName": "Antibody-drug Conjugate SC-007",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C1512"
    ],
    "synonyms": [
      "ADC SC-007",
      "Antibody-drug Conjugate SC-007",
      "SC-007"
    ]
  }
}